Editas Medicine (EDIT) Prices First IPO of 2016
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Needham Starts NeoVolta (NEOV) at Buy
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Editas Medicine (EDIT) IPO Opens Flat
February 3, 2016 11:03 AM ESTToday's IPO for Editas Medicine (NASDAQ: EDIT) opened for trading at $16.10 after pricing 5,900,000 shares at $16 per share, the low end of the expected $16-$18 range.
The offering was led by Morgan Stanley, JP Morgan, Cowen and JMP Securities.
Editas Medicine is a... More
